Abstract:Background: Recently, celastrol shows great potential for inducing apoptosis in the treatment of leukemia, especially acute promyelocytic leukemia. However, the mechanism is poorly understood. Metabolomics provides overall understanding of biological mechanisms by surveying small molecules, which contributes to the illustration of celastrol's action mode. Methods: We treated nude mice bearing xenografts of HL-60 cell in vivo and HL-60 cell as well as NB-4 cell in vitro with celastrol. UPLC coupled to an Orbitrap mass spectrometer was used for a hypothesis free metabolomics analysis of HL-60 in vivo, and was used for targeted L-cysteine analysis of HL-60 and NB-4 cells. Flow cytometry analysis was performed to detect the mitochondrial membrane potential, production of reactive oxygen species (ROS) and percentage of apoptosis. Western blot was conducted to detect the protein level of p53, Bax, cleaved caspase 9 and cleaved caspase 3. Findings: Celastrol inhibited tumor growth, induced apoptosis, and up-regulated pro-apoptotic proteins in xenograft tumor mice model. Metabolomics profiles delineated cysteine metabolism was the key changed metabolism after celastrol treatment in HL-60 cells in vivo. Celastrol decreased L-cysteine in HL-60 cells. The supplementation of acetylcysteine reversed the ROS and apoptosis induced by celastrol, and reversed the dramatic decline of mitochondrial membrane potential and the up-regulation of pro-apoptotic proteins in HL-60 cells. Celastrol decreased L-cysteine, and acetylcysteine reversed ROS and apoptosis induced by celastrol in NB-4 cells. Interpretation: We firstly identified cysteine metabolism/ROS/p53/Bax/caspase 9/caspase 3 pathway in celastrol-triggered apoptosis of APL cells, providing a novel mechanism underlying which celastrol might be used for the treatment of acute promyelocytic leukemia. Funding: This study was supported by grants from the National Natural Science Foundation of China (81872650, 81503134, 81573182); the Key Natural Science Foundation of the Jiangsu Higher Education Institutions of China (18KJA320003); the Key Project of the Science and Technology Development Foundation of Nanjing Medical University (2014NJMUZD005); the Key Research & Development Plan of Jiangsu Province (BE2017628); the Southeast University & Nanjing Medical University Collaborative Research Project (2242018K3DN25); the Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). Declaration of Interest: The authors declare that they have no competing interests.Ethical Approval: All procedures performed in studies involving animals were in accordance with the ethical standards of Nanjing Medical 419 University Institutional Animal Care and Use Committee.

Effects of Celastrol on proliferation and apoptosis of acute promyelocyticl eukemia cell lines NB4

[Study on Matrine Alleviating Retinoic Acid Resistance in Acute Promyelocytic Leukemia].

[Inhibition of Proliferation of Adult T-cell Leukemia Cells by Celastrol].

The Effect of Celastrol on Prostate Cancer Cells Apoptosis and SENP1 Gene Expression

Metabolomics Reveals Cysteine Metabolism Plays a Role in Celastrol-Induced Mitochondrial Apoptosis of Acute Promyelocytic Leukemia Cells

Metabolomics profiles delineate uridine deficiency contributes to mitochondria-mediated apoptosis induced by celastrol in human acute promyelocytic leukemia cells

Metabolomics Reveals that Cysteine Metabolism Plays a Role in Celastrol-Induced Mitochondrial Apoptosis in HL-60 and NB-4 Cells

NF-Kappa B Modulation Is Involved in Celastrol Induced Human Multiple Myeloma Cell Apoptosis

Berbamine Selectively Induces Apoptosis of Human Acute Promyelocytic Leukemia Cells Via Survivin-Mediated Pathway

Effects of Celastrol on Human Cervical Cancer Cells As Revealed by Ion-Trap Gas Chromatography–mass Spectrometry Based Metabolic Profiling

Effects of Berbamine on Growth of Leukemia Cell Line NB4 and Its Mechanism

Studies on the Effects of Berbamine on the Human Leukemia Cell Line Nb4.

Effects of lapatinib on cell proliferation and apoptosis in NB4 cells

Celastrol Inhibits Lung Infiltration in Differential Syndrome Animal Models by Reducing TNF-α and ICAM-1 Levels While Preserving Differentiation in ATRA-Induced Acute Promyelocytic Leukemia Cells

Celastrol Induces Apoptosis in Non-Small-Cell Lung Cancer A549 Cells Through Activation of Mitochondria- and Fas/Fasl-Mediated Pathways

Celastrol Elicits Antitumor Effects by Inhibiting the STAT3 Pathway Through ROS Accumulation in Non-Small Cell Lung Cancer

Inhibit the Proliferation of Leukemia Cell Line NB_4-R2 with All-Transretinoic Acid-Resistant in Vitro by Bortezomib

The Effects of Celastrol on the Apoptosis and Cell Cycle Arrest of C6 Glioma Cells and Its Mechanism

Effects of Bone Marrow Stromal Cells and Antibody Against Late Antigen-4 Combined with Ara-C on Proliferation and Apoptosis of HL-60 Cells

Up-regulation of Death Receptor 4 and 5 by Celastrol Enhances the Anti-Cancer Activity of TRAIL/Apo-2L.

Celastrol, a novel HSP90 inhibitor, depletes Bcr-Abl and induces apoptosis in imatinib-resistant chronic myelogenous leukemia cells harboring T315I mutation.